We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · May 18, 2021

Initial Firstline Treatment and Re-Treatment With Etanercept in Patients With Juvenile Idiopathic Arthritis

Arthritis research & therapy


Additional Info

Arthritis research & therapy
Re-Treatment With Etanercept Is as Effective as the Initial Firstline Treatment in Patients With Juvenile Idiopathic Arthritis
Arthritis Res. Ther. 2021 Apr 16;23(1)118, J Klotsche, A Klein, M Niewerth, P Hoff, D Windschall, I Foeldvari, JP Haas, G Horneff, K Minden

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading